The Head of HTA, COA, and PED in Global Evidence Generation is responsible for leading a team of experts to develop, validate, and execute fit-for-purpose clinical outcome assessment (COA) endpoints, patient experience data (PED) strategies and high-quality evidence generation to support health technology assessment (HTA) and payer differentiation around the world. This highly strategic role will drive early and innovative strategic decision making and high-quality execution for clinical outcome assessment, PRO (patient reported outcomes), and PED to support study execution, labeling, differentiation, payer and HTA interactions, and patient focus, in collaboration with internal and external stakeholders.